{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-005268","form_type":"8-K","ticker":null,"cik":"0001008586","company_name":"STREAMLINE HEALTH SOLUTIONS INC.","filed_at":"2024-02-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.077131+00:00","generated_at":"2026-06-06T06:18:32.100995+00:00","sec_items":["1.01","2.03","3.02","5.02","7.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Streamline Health raises ~$4.5M, modifies credit facility, appoints two directors","bullets":["Aggregate gross proceeds ~$4.5M: $4.4M notes bearing 15% interest (maturity 8/7/26) and $100K common stock; warrants for 4,052,631 shares at $0.38 strike.","Modified Western Alliance Bank credit facility: updated debt-to-EBITDA thresholds, removed minimum cash and max debt-to-ARR covenants, added quarterly adjusted EBITDA targets.","Appointed CEO Benjamin Stilwill and Matthew Etheridge to board effective Feb 7, 2024; board expanded to seven.","Company expects liquidity to enable adjusted EBITDA breakeven run rate of $15.5M installed SaaS ARR in H2 fiscal 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-005268","json":"https://secwatch.observer/filing/0001493152-24-005268.json","markdown":"https://secwatch.observer/filing/0001493152-24-005268.md","text":"https://secwatch.observer/filing/0001493152-24-005268.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1008586/000149315224005268/0001493152-24-005268-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1008586/000149315224005268/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T06:18:32.100995+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0b8d92b51d59a79833b7fe8bc83af39f38dea91f","claim":"STREAMLINE HEALTH SOLUTIONS INC. amended credit facility with Western Alliance Bank.","evidence_excerpt":"On February 7, 2024, the Company and certain of its subsidiaries entered into a Third Modification and Waiver (the “Third Modification”) to Second Amended and Restated Loan and Security Agreement (the “Loan and Security Agreement”) with WAB.","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1008586/000149315224005268/0001493152-24-005268-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"credit facility"},{"label":"Counterparty","value":"Western Alliance Bank"},{"label":"Event","value":"amendment"}],"fact_type":"debt_financing"},{"claim_id":"c1735a907c","claim":"Matthew Etheridge was appointed as Director at STREAMLINE HEALTH SOLUTIONS INC..","evidence_excerpt":"appointed Benjamin L. Stilwill and Matthew Etheridge to serve as directors of the Company, effective as of the closing of the Debt Private Placement on February 7, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1008586/000149315224005268/0001493152-24-005268-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"da8063f877","claim":"Benjamin L. Stilwill was appointed as Director at STREAMLINE HEALTH SOLUTIONS INC..","evidence_excerpt":"appointed Benjamin L. Stilwill and Matthew Etheridge to serve as directors of the Company, effective as of the closing of the Debt Private Placement on February 7, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1008586/000149315224005268/0001493152-24-005268-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"400ff113f5a4a23c8522b33a86755d3781324729","claim":"STREAMLINE HEALTH SOLUTIONS INC. entered into Securities Purchase Agreement with certain accredited investors, including certain directors and officers of the Company (collectively, the \"Investors\") valued at aggregate principal amount of $4.4 million (effective 2024-02-01).","evidence_excerpt":"On February 1, 2024, Streamline Health Solutions, Inc. (the “Company”) entered into a securities purchase agreement (the “Securities Purchase Agreement”) with certain accredited investors, including certain directors and officers of the Company (collectively, the “Investors”), pursuant to which the Company agreed to sell to the Investors unsecured subordinated promissory notes (the “Notes”) in the aggregate principal amount of $4.4 million and warrants","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1008586/000149315224005268/0001493152-24-005268-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"certain accredited investors, including certain directors and officers of the Company (collectively, the \"Investors\")"},{"label":"Value","value":"aggregate principal amount of $4.4 million"},{"label":"Effective","value":"2024-02-01"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}